ENTRADA THERAPEUTICS INC has a total of 13 patent applications. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are JIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD, VIANEX S A and SHAANXI HUIKANG BIO TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 1 | |
#4 | Hungary | 1 | |
#5 | Japan | 1 | |
#6 | Serbia | 1 | |
#7 | Taiwan | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Pei Dehua | 13 |
#2 | Qian Ziqing | 12 |
#3 | Sethuraman Natarajan | 5 |
#4 | Ruth Jason | 5 |
#5 | Tartaglia Lou | 4 |
#6 | Qian Zi-Qing | 1 |
#7 | Tartaglia Lou A | 1 |
Publication | Filing date | Title |
---|---|---|
TW201945014A | Compositions and methods for treating Mitochondrial Neurogastrointestinal Encephalopathy | |
US2017355730A1 | Cell penetrating peptides and methods of making and using thereof |